Ming Ye
Bengbu, 233004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical utility of CSF metagenomic next-generation sequencing in suspected CNS infection: performance against a composite reference standard and read-count stratification.
Journal: Frontiers in cellular and infection microbiology
Published: June 10, 2026
Changes in the intestinal microbiota of patients with Parkinson's disease and their clinical significance.
Journal: International journal of clinical pharmacology and therapeutics
Published: November 24, 2022
The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson's Disease.
Journal: Neuromolecular medicine
Published: October 10, 2022
B.infantis enhances immunotherapy for Guillain-Barre syndrome through regulating PD-1.
Journal: BMC neurology
Published: December 22, 2021
Pathogenic mechanism of intestinal microbiota involved in Guillain-Barré syndrome and with Bifidobacterium intervention.
Journal: Archives of medical science : AMS
Published: June 30, 2020
Treatment of Guillain-Barré syndrome with Bifidobacterium infantis through regulation of T helper cells subsets.
Journal: International immunopharmacology
Published: March 29, 2018
DL-3-n-butylphthalide therapy for Parkinson's disease: A randomized controlled trial.
Journal: Experimental and therapeutic medicine
Published: January 23, 2018
Protection of Rho-associated protein kinase inhibitor Y-27632 in MRL/lpr mice
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: July 18, 2017
DL‑3‑n‑butylphthalide reduces microglial activation in lipopolysaccharide‑induced Parkinson's disease model mice.
Journal: Molecular medicine reports
Published: March 28, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026